HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q1 2024 investor call Tuesday, June 18th at 10 a.m. ET. Results will be released prior to the call. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference and Q&A session.
Conference Call Details Date / Time: Tuesday, June 18th at 10 a.m. ETCall Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int’lLive Webcast / Replay: Webcast & Replay Link – Available for 3 months.Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 1988012 BIO-key at a Glance Recent Price $1.76 2023 Revenue $7.8MShares Out.* 1.9M 2023 Revenue Growth +10.5%Market Cap $3.3M Price/2023 Sales 0.4X
* Common stock and common stock equivalents outstanding.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 40 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Engage with BIO-key Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international Twitter – Corporate: @BIOkeyIntlTwitter – Investors: @BIO_keyIRStockTwits: BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800